The optimal ribavirin dose for patients infected with hepatitis C virus genotype 3: should we utilize more?
Aghemo
Alessio
A
Rumi
Maria Grazia
MG
Prati
Gian Maria
GM
Colombo
Massimo
M
D004305:Dose-Response Relationship, Drug; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D012254:Ribavirin / Q000009:adverse effects / Q000627:therapeutic use*
D012254:Ribavirin